Acadia Pharmaceuticals ACAD Cash Flow Statement (2010-2026)

NASDAQ ACAD
$20.33 -0.11 (-0.54%)
As of: Oct 21, 2026 · 11:41 AM EDT
Reported Financials

Acadia Pharmaceuticals Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Acadia Pharmaceuticals reported cash from operations of $100.78M and free cash flow of $95.69M for the quarter ended Jun 2026, up 57.6% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-14.46M-43.09M-113.06M-34.01M-27.18M-41.73M-43.02M1.11M-65.18M45.80M16.56M33.39M32.77M143.74M18.99M26.67M71.78M273.57M3.64M31.50M
Depreciation and DepletionDep. & Depletion
0.62M0.54M0.52M0.52M0.51M0.49M0.43M0.40M0.36M0.31M0.24M0.23M0.23M0.23M0.23M0.21M0.23M0.23M0.27M0.43M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.40M1.36M1.36M1.37M5.29M2.35M2.34M4.99M2.72M2.72M2.72M2.72M2.72M2.72M
Depreciation & Amortization (CF)Dep. & Amort.
0.62M0.54M0.52M0.52M0.51M0.49M0.43M0.40M0.36M0.31M0.24M0.23M0.23M0.23M0.23M0.21M0.23M0.23M0.27M0.43M
Share-based CompensationStock Comp.
15.55M12.88M14.96M20.51M18.31M14.41M14.71M15.15M18.54M18.02M14.75M15.69M26.16M10.45M11.38M14.34M13.18M13.24M14.70M16.94M
Deferred Taxes
-0.09M9.77M
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
0.38M1.62M0.34M-0.50M2.16M1.54M4.85M-1.24M1.51M
Other non-cash itemsOther Non-Cash
Change in Working Capital
Change in ReceivablesChange Receivables
9.33M3.67M-1.65M5.24M-12.22M6.46M3.72M15.94M10.95M5.47M-3.57M9.00M2.64M-6.20M7.00M1.76M8.86M5.09M13.89M15.30M
Change in InventoryChange Inventory
3.55M-0.22M-0.83M-0.63M-0.64M-0.31M-0.48M3.00M11.22M15.07M16.65M27.15M1.33M4.42M10.45M4.10M-1.25M4.89M-0.08M-3.90M
Change in Account PayablesChange Payables
-1.34M-0.85M3.89M1.09M-1.85M2.74M4.68M1.39M-6.50M5.23M1.79M0.55M-0.80M-2.89M1.90M2.00M1.65M-10.84M1.34M32.32M
Change in Accured ExpensesChange Accured Exp.
-5.93M8.81M19.67M-2.82M0.92M6.54M24.51M2.37M28.16M38.13M12.19M14.85M13.24M30.78M-0.12M21.47M27.78M-68.39M23.56M22.53M
Change in Other Operating AssetsOther Assets Change
-1.59M-0.73M1.86M-4.80M-2.80M3.30M2.23M0.38M13.97M1.14M3.67M3.30M5.38M4.13M-2.39M0.77M8.82M-0.49M5.11M4.39M
Change in Other Operating LiabilitiesOther Liabilities Change
-1.77M0.82M-4.78M-0.68M-1.07M0.65M-5.43M2.27M1.73M1.63M-3.66M-1.21M-2.74M2.93M2.28M6.80M-16.84M2.33M-8.68M0.82M
Other Working Capital ChangesOther WC Changes
-0.18M1.55M-6.64M4.12M1.74M-2.65M-7.66M1.89M-12.24M0.49M-7.33M-4.51M-8.12M-1.20M4.67M6.03M-25.66M2.82M-13.79M-3.57M
Other Operating ActivitiesOther Ops.
Cash from OperationsCash from Ops.
-17.06M-23.12M-76.33M-13.13M-0.73M-23.85M-17.93M8.20M-58.96M85.39M29.08M25.01M63.25M40.38M20.32M63.96M74.29M-48.73M33.98M100.78M
Investing Activities
Capital ExpendituresCapex
0.00M0.07M0.45M0.30M0.39M4.01M5.21M5.09M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
0.00M-0.07M-0.45M-0.30M-0.39M-4.01M-5.21M-5.09M
Change in IntangiblesChange Intangibless
98.84M
Purchase of InvestmentsInvestments Purchased
251.32M38.95M125.38M144.25M93.55M66.89M161.78M37.20M104.11M80.15M137.69M151.49M135.76M156.01M174.39M204.55M157.61M15.01M93.44M
Sale and Maturity of InvestmentsInvestments Sold
95.00M110.50M131.35M69.58M159.69M75.80M259.41M7.50M59.11M103.76M66.12M81.50M69.10M111.85M130.80M131.39M125.59M105.75M86.50M90.00M
Cash from Investing ActivitiesCash from Investing
-156.32M71.55M131.35M-55.80M15.44M-17.75M192.52M-194.28M34.11M-0.35M-14.04M-56.19M-82.46M122.15M-124.05M-43.29M-79.35M-55.87M66.28M-8.53M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
1.07M4.37M2.47M3.83M0.29M1.61M1.47M5.48M12.75M5.43M1.04M3.57M0.27M1.97M1.84M15.96M9.42M22.67M4.23M10.49M
Net Shares Issued and RepurchasedNet Shares Issued
1.07M4.37M2.47M3.83M0.29M1.61M1.47M5.48M12.75M5.43M1.04M3.57M0.27M1.97M1.84M15.96M9.42M22.67M4.23M10.49M
Net Equity Issued and RepurchasedNet Equity Issued
1.07M4.37M2.47M3.83M0.29M1.61M1.47M5.48M12.75M5.43M1.04M3.57M0.27M1.97M1.84M15.96M9.42M22.67M4.23M10.49M
Cash from Financing ActivitiesCash from Financing
1.07M4.37M2.47M3.83M0.29M1.61M1.47M5.48M12.75M5.43M1.04M3.57M0.27M1.97M1.84M15.96M9.42M22.67M4.23M10.49M
Additional items
Exchange Rate EffectFX Effect
0.00M0.00M0.00M0.00M0.01M-0.01M0.00M0.00M-0.01M0.01M0.00M-0.04M-0.06M-0.01M0.02M0.01M0.03M0.03M
Change in Cash
-172.32M52.80M57.49M-65.09M15.01M-40.00M176.05M-180.60M-12.10M90.46M16.09M-27.61M-18.99M164.44M-101.89M36.64M4.36M-81.93M104.52M102.77M
Free Cash FlowFCF
-17.06M-23.12M-76.33M-13.13M-0.73M-23.85M-17.93M8.20M-58.96M85.39M29.08M25.01M63.18M39.93M20.32M63.66M73.90M-52.74M28.77M95.69M
Net Cash FlowNCF
-172.32M52.79M57.48M-65.09M15.00M-39.99M176.05M-180.60M-12.09M90.48M16.08M-27.61M-18.94M164.50M-101.89M36.62M4.36M-81.93M104.49M102.75M

Acadia Pharmaceuticals Cash Flow Statement API

Pull Acadia Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ACAD&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY